logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – One in six premenopausal breast cancer patients inadequately adherent to tamoxifen after one year

French study is the first to assess adherence using serum tamoxifen levels rather than self-declaration